MassMutual Private Wealth & Trust’s Acadia Pharmaceuticals ACAD Stock Holding History

MassMutual Private Wealth & Trust’s Portfolio ACAD Stock Details ACAD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.57K	Hold	62	–	–	﹤0.01%	2068
2026 Q1	$1.38K	Hold	62	–	–	﹤0.01%	2061
2025 Q4	$1.66K	Hold	62	–	–	﹤0.01%	2048
2025 Q3	$1.32K	Hold	62	–	–	﹤0.01%	2094
2025 Q2	$1.34K	Buy	+62	New	+$1.15K	﹤0.01%	2049
2022 Q1	–	Sell	-25	Closed	-$1K	–	1498
2021 Q4	$1K	Buy	+25	New	+$503	﹤0.01%	1151
2017 Q1	–	Sell	-132	Closed	-$3.81K	–	1030
2016 Q4	$3.81K	Buy	+132	New	+$3.49K	﹤0.01%	557
2016 Q2	$331K	Buy	10,201 +207	+2%	+$6.93K	0.04%	252
2016 Q1	$279K	Buy	+9,994	New	+$218K	0.04%	251

Other funds holding ACAD

Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return

ALPS Advisors Denver, Colorado $21.3B AUM 23.41% 1-Year Est. Return

New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return

EAM

Erste Asset Management Vienna, Austria $12.9B AUM 52.69% 1-Year Est. Return

HWAM

Hennion & Walsh Asset Management Parsippany, New Jersey $3.5B AUM 41.95% 1-Year Est. Return

WesBanco Bank Wheeling, West Virginia $4.02B AUM 32.62% 1-Year Est. Return

SOADOR

State of Alaska Department of Revenue Juneau, Alaska $10.1B AUM 42.83% 1-Year Est. Return

PFC

Phocas Financial Corp Alameda, California $721M AUM 63.77% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

LSERS

Louisiana State Employees Retirement System Baton Rouge, Louisiana $6.74B AUM 53.06% 1-Year Est. Return

MassMutual Private Wealth & Trust's ACAD Position: Q2 2026 in Review

MassMutual Private Wealth & Trust held its Acadia Pharmaceuticals (ACAD) position steady in Q2 2026 at 62 shares worth $1.57K. The position accounts for ﹤0.01% of the portfolio, ranked #2068.

MassMutual Private Wealth & Trust first reported a position in ACAD in Q1 2016 and has held it in 9 quarters since. The position peaked at $331K in Q2 2016. 82 funds tracked by Wall St. Rank hold ACAD as of Q2 2026.

MassMutual Private Wealth & Trust held 62 shares of Acadia Pharmaceuticals worth $1.57K as of Q2 2026.
MassMutual Private Wealth & Trust left its Acadia Pharmaceuticals share count unchanged in Q2 2026.
Acadia Pharmaceuticals made up ﹤0.01% of MassMutual Private Wealth & Trust's portfolio in Q2 2026, its #2068 holding.
MassMutual Private Wealth & Trust first reported a position in Acadia Pharmaceuticals in Q1 2016 and has held it in 9 quarters since.
MassMutual Private Wealth & Trust's Acadia Pharmaceuticals position peaked at $331K in Q2 2016.
82 funds tracked by Wall St. Rank held Acadia Pharmaceuticals as of Q2 2026.

Based on MassMutual Private Wealth & Trust's 13F filing for Q2 2026, filed 2 Jul 2026.